SPDR S&P Biotech ETF

Fund Name:
SPDR S&P Biotech ETF
State Street
Total Net Assets:
Related Index:
S&P Biotech Select Industry Index
ETF Category: 
Expense Ratio: 
Net Asset Value: 
Recent NAV Premium: 
NAV Symbol: 
Number of Holdings: 
Annualized Yield: 
Annualized Distribution: 
XBI Dividend History » 
Stock Weight Amount
Array Biopharma 2.14% $106,716,054
Sarepta Therapeutics 2.08% $103,912,609
Loxo Oncology 1.98% $98,721,316
Immunogen 1.92% $95,476,697
Avexis 1.77% $88,248,160
List of all 108 stocks held by XBI »
Quotes delayed 20 minutes

Buy (3.33 out of 4)
93rd percentile
(ranked higher than approx. 93% of all etfs covered)
Based on data provided by Zacks Investment Research via
ETF Assets
SPY   $270,227,892,071
GLD   $35,173,603,881
XLF   $33,385,863,352
DIA   $22,706,590,286
XLK   $21,457,647,786
List of all 133 others »
Shares Short 30,076,400
Chg. from Last Month +1,521,700
Shares Outstanding 53,450,000
% of Shares Short 56.27%
Days to Cover 8.8
Based on data powered by

XBI | SPDR S&P Biotech ETF | ETF Channel |

Copyright © 2010 - 2018, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.